Ann: Placement, page-23

The following is; 'The Summary of ASX announcement , 16 October 2020.'

IN SUMMARY
“We are making significant progress and attracting strong interest from potential strategic partners
and prospective investors based on the data being generated. Benchtop and pre-clinical trials are
providing critical insights and valuable data in the development of our 3D single-piece aortic valve.
The results of these studies and the data generated to date in our First In Human study reinforce
that DurAVR™ can deliver valve function that replicates a pre-diseased valve. If we keep
generating these outcomes, it will provide a functional cure for those patients suffering from severe
aortic stenosis,” Wayne Paterson, Anteris CEO, said.
----------------------------------
We've basically had positive press on the company since this announcement.
The sky isn't falling, as far as I can see.
I go along with 'ChillyDog', if we can get away with a $mill, why take more.
I don't want anymore dilution than necessary.
WP may have made some mistakes, but I have given up living in the past and can't wait for this great product to be able to be used in everyday surgery.
A good friend of mine needs one .
How close is the partner of choice to signing....this is best in class design and I don't think you'd want to wait until all the boxes are ticked before you put your money on the table.....because you are very likely to miss out!!

I'm not going to loose any sleep.
Cheers
Dabru